{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T19:51:17Z","timestamp":1791143477546,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2013,2,17]],"date-time":"2013-02-17T00:00:00Z","timestamp":1361059200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1007\/s00296-013-2705-4","type":"journal-article","created":{"date-parts":[[2013,2,18]],"date-time":"2013-02-18T15:38:49Z","timestamp":1361201929000},"page":"2109-2115","source":"Crossref","is-referenced-by-count":11,"title":["The distinct expressions of interleukin-15 and interleukin-15 receptor \u03b1 in Beh\u00e7et\u2019s disease"],"prefix":"10.1007","volume":"33","author":[{"given":"Jung-Yoon","family":"Choe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hwajeong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Gyung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Ji","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Hoon","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong-Kyu","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,2,17]]},"reference":[{"key":"2705_CR1","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1056\/NEJM199910213411707","volume":"341","author":"T Sakane","year":"1999","unstructured":"Sakane T, Takeno M, Suzuki N, Inaba G (1999) Behcet\u2019s disease. N Engl J Med 341:1284\u20131291","journal-title":"N Engl J Med"},{"key":"2705_CR2","first-page":"588","volume":"19","author":"Y Suzuki","year":"1992","unstructured":"Suzuki Y, Hoshi K, Matsuda T, Mizushima Y (1992) Increased peripheral blood \u03b3\u03b4+ T cells and natural killer cells in Beh\u00e7et\u2019s disease. J Rheumatol 19:588\u2013592","journal-title":"J Rheumatol"},{"key":"2705_CR3","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1365-2249.2004.02536.x","volume":"137","author":"HG Yu","year":"2004","unstructured":"Yu HG, Lee DS, Seo JM, Ahn JK, Yu YS, Lee WJ et al (2004) The number of CD8+ T cells and NKT cells increases in the aqueous humor of patients with Beh\u00e7et\u2019s uveitis. Clin Exp Immunol 137:437\u2013443","journal-title":"Clin Exp Immunol"},{"key":"2705_CR4","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1136\/ard.55.2.128","volume":"55","author":"S Sahin","year":"1996","unstructured":"Sahin S, Ako\u011flu T, Direskeneli H, Sen LS, Lawrence R (1996) Neutrophil adhesion to endothelial cells and factors affecting adhesion in patients with Beh\u00e7et\u2019s disease. Ann Rheum Dis 55:128\u2013133","journal-title":"Ann Rheum Dis"},{"key":"2705_CR5","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s004030000128","volume":"292","author":"CC Zouboulis","year":"2000","unstructured":"Zouboulis CC, Katsantonis J, Ketteler R, Treudler R, Kaklamani E, Hornemann S et al (2000) Adamantiades-Beh\u00e7et\u2019s disease: interleukin-8 is increased in serum of patients with active oral and neurological manifestations and is secreted by small vessel endothelial cells. Arch Dermatol Res 292:279\u2013284","journal-title":"Arch Dermatol Res"},{"key":"2705_CR6","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1080\/09629350220131935","volume":"11","author":"C Evereklioglu","year":"2002","unstructured":"Evereklioglu C, Er H, T\u00fcrk\u00f6z Y, Cekmen M (2002) Serum levels of TNF-\u03b1, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Beh\u00e7et\u2019s disease. Mediators Inflamm 11:87\u201393","journal-title":"Mediators Inflamm"},{"key":"2705_CR7","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1126\/science.8178155","volume":"264","author":"KH Grabstein","year":"1994","unstructured":"Grabstein KH, Eisenman J, Shanebeck K, Rauch C, Srinivasan S, Fung V et al (1994) Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor. Science 264:965\u2013968","journal-title":"Science"},{"key":"2705_CR8","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1146\/annurev.immunol.17.1.19","volume":"17","author":"TA Waldmann","year":"1999","unstructured":"Waldmann TA, Tagaya Y (1999) The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens. Annu Rev Immunol 17:19\u201349","journal-title":"Annu Rev Immunol"},{"key":"2705_CR9","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.imlet.2009.09.009","volume":"127","author":"SW Stonier","year":"2010","unstructured":"Stonier SW, Schluns KS (2010) Trans-presentation: a novel mechanism regulating IL-15 delivery and responses. Immunol Lett 127:85\u201392","journal-title":"Immunol Lett"},{"key":"2705_CR10","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S1074-7613(02)00429-6","volume":"17","author":"S Dubois","year":"2002","unstructured":"Dubois S, Mariner J, Waldmann TA, Tagaya Y (2002) IL-15R\u03b1 recycles and presents IL-15 In trans to neighboring cells. Immunity 17:537\u2013547","journal-title":"Immunity"},{"key":"2705_CR11","first-page":"639","volume":"21","author":"I Gonzalez-Alvaro","year":"2003","unstructured":"Gonzalez-Alvaro I, Ortiz AM, Garcia-Vicu\u00f1a R, Balsa A, Pascual-Salcedo D, Laffon A (2003) Increased serum levels of interleukin-15 in rheumatoid arthritis with long- term disease. Clin Exp Rheumatol 21:639\u2013642","journal-title":"Clin Exp Rheumatol"},{"key":"2705_CR12","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nm0297-189","volume":"3","author":"IB McInnes","year":"1997","unstructured":"McInnes IB, Leung BP, Sturrock RD, Field M, Liew FY (1997) Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-\u03b1 production in rheumatoid arthritis. Nat Med 3:189\u2013195","journal-title":"Nat Med"},{"key":"2705_CR13","first-page":"2389","volume":"28","author":"J Suzuki","year":"2001","unstructured":"Suzuki J, Morimoto S, Amano H, Tokano Y, Takasaki Y, Hashimoto H (2001) Serum levels of interleukin 15 in patients with rheumatic diseases. J Rheumatol 28:2389\u20132391","journal-title":"J Rheumatol"},{"key":"2705_CR14","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1093\/rheumatology\/kei083","volume":"44","author":"L Baranda","year":"2005","unstructured":"Baranda L, de la Fuente H, Layseca-Espinosa E, Portales-P\u00e9rez D, Ni\u00f1o-Moreno P, Valencia-Pacheco G et al (2005) IL-15 and IL-15R in leucocytes from patients with systemic lupus erythematosus. Rheumatology (Oxford) 44:1507\u20131513","journal-title":"Rheumatology (Oxford)"},{"key":"2705_CR15","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.imlet.2008.07.009","volume":"121","author":"SJ Curnow","year":"2008","unstructured":"Curnow SJ, Pryce K, Modi N, Knight B, Graham EM, Stewart JE et al (2008) Serum cytokine profiles in Beh\u00e7et\u2019s disease: is there a role for IL-15 in pathogenesis? Immunol Lett 121:7\u201312","journal-title":"Immunol Lett"},{"key":"2705_CR16","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/j.1365-3083.2006.01844.x","volume":"64","author":"K Hamzaoui","year":"2006","unstructured":"Hamzaoui K, Hamzaoui A, Ghorbel I, Khanfir M, Houman H (2006) Levels of IL-15 in serum and cerebrospinal fluid of patients with Beh\u00e7et\u2019s disease. Scand J Immunol 64:655\u2013660","journal-title":"Scand J Immunol"},{"key":"2705_CR17","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.ajo.2006.04.016","volume":"142","author":"JK Ahn","year":"2006","unstructured":"Ahn JK, Yu HG, Chung H, Park YG (2006) Intraocular cytokine environment in active Beh\u00e7et uveitis. Am J Ophthalmol 142:429\u2013434","journal-title":"Am J Ophthalmol"},{"key":"2705_CR18","first-page":"1078","volume":"335","author":"International Study Group for Behcet\u2019s disease","year":"1990","unstructured":"International Study Group for Behcet\u2019s disease (1990) Criteria for diagnosis of Behcet\u2019s disease. Lancet 335:1078\u20131080","journal-title":"Lancet"},{"key":"2705_CR19","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/art.1780251101","volume":"25","author":"EM Tan","year":"1982","unstructured":"Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271\u20131277","journal-title":"Arthritis Rheum"},{"key":"2705_CR20","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","volume":"40","author":"MC Hochberg","year":"1997","unstructured":"Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classifi cation of systemic lupus erythematosus. Arthritis Rheum 40:1725","journal-title":"Arthritis Rheum"},{"key":"2705_CR21","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315\u2013324","journal-title":"Arthritis Rheum"},{"key":"2705_CR22","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1136\/ard.57.1.45","volume":"57","author":"I Fresko","year":"1998","unstructured":"Fresko I, Soy M, Hamuryudan V, Yurdakul S, Yavuz S, T\u00fcmer Z et al (1998) Genetic anticipation in Beh\u00e7et\u2019s syndrome. Ann Rheum Dis 57:45\u201348","journal-title":"Ann Rheum Dis"},{"key":"2705_CR23","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/0008-8749(92)90207-6","volume":"140","author":"S Hirohata","year":"1992","unstructured":"Hirohata S, Oka H, Mizushima Y (1992) Streptococcal-related antigens stimulate production of IL6 and interferon-gamma by T cells from patients with Behcet\u2019s disease. Cell Immunol 140:410\u2013419","journal-title":"Cell Immunol"},{"key":"2705_CR24","doi-asserted-by":"crossref","first-page":"4322","DOI":"10.4049\/jimmunol.160.9.4322","volume":"160","author":"VE Garc\u00eda","year":"1998","unstructured":"Garc\u00eda VE, Jullien D, Song M, Uyemura K, Shuai K, Morita CT et al (1998) IL-15 enhances the response of human \u03b3\u03b4 T cells to nonpeptide microbial antigens. J Immunol 160:4322\u20134329","journal-title":"J Immunol"},{"key":"2705_CR25","doi-asserted-by":"crossref","first-page":"800","DOI":"10.4049\/jimmunol.158.2.800","volume":"158","author":"D Jullien","year":"1997","unstructured":"Jullien D, Sieling PA, Uyemura K, Mar ND, Rea TH, Modlin RL (1997) IL-15, an immunomodulator of T cell responses in intracellular infection. J Immunol 158:800\u2013806","journal-title":"J Immunol"},{"key":"2705_CR26","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1172\/JCI1986","volume":"101","author":"N Oppenheimer-Marks","year":"1998","unstructured":"Oppenheimer-Marks N, Brezinschek RI, Mohamadzadeh M, Vita R, Lipsky PE (1998) Interleukin 15 is produced by endothelial cells and increases the transendothelial migration of T cells In vitro and in the SCID mouse-human rheumatoid arthritis model In vivo. J Clin Invest 101:1261\u20131272","journal-title":"J Clin Invest"},{"key":"2705_CR27","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000045365","volume":"82","author":"K Matsumoto","year":"1999","unstructured":"Matsumoto K, Ohi H, Kanmatsuse K (1999) Effects of interleukin-15 on vascular permeability factor release by peripheral blood mononuclear cells in normal subjects and in patients with minimal-change nephrotic syndrome. Nephron 82:32\u201338","journal-title":"Nephron"},{"key":"2705_CR28","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1093\/rheumatology\/40.8.876","volume":"40","author":"M Aringer","year":"2001","unstructured":"Aringer M, Stummvoll GH, Steiner G, K\u00f6ller M, Steiner CW, H\u00f6fler E (2001) Serum interleukin-15 is elevated in systemic lupus erythematosus. Rheumatology (Oxford) 40:876\u2013881","journal-title":"Rheumatology (Oxford)"},{"key":"2705_CR29","doi-asserted-by":"crossref","first-page":"3654","DOI":"10.1002\/j.1460-2075.1995.tb00035.x","volume":"14","author":"JG Giri","year":"1995","unstructured":"Giri JG, Kumaki S, Ahdieh M, Friend DJ, Loomis A, Shanebeck K (1995) Identification and cloning of a novel IL-15 binding protein that is structurally related to the alpha chain of the IL-2 receptor. EMBO J 14:3654\u20133663","journal-title":"EMBO J"},{"key":"2705_CR30","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1084\/jem.20071913","volume":"205","author":"E Mortier","year":"2008","unstructured":"Mortier E, Woo T, Advincula R, Gozalo S, Ma A (2008) IL-15Ralpha chaperones IL-15 to stable dendritic cell membrane complexes that activate NK cells via trans presentation. J Exp Med 205:1213\u20131225","journal-title":"J Exp Med"},{"key":"2705_CR31","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.4049\/jimmunol.173.3.1681","volume":"173","author":"E Mortier","year":"2004","unstructured":"Mortier E, Bernard J, Plet A, Jacques Y (2004) Natural, proteolytic release of a soluble form of human IL-15 receptor alpha-chain that behaves as a specific, high affinity IL-15 antagonist. J Immunol 173:1681\u20131688","journal-title":"J Immunol"},{"key":"2705_CR32","doi-asserted-by":"crossref","first-page":"3373","DOI":"10.1002\/eji.200737488","volume":"37","author":"WA Verri Jr","year":"2007","unstructured":"Verri WA Jr, Cunha TM, Ferreira SH, Wei X, Leung BP, Fraser A (2007) IL-15 mediates antigen-induced neutrophil migration by triggering IL-18 production. Eur J Immunol 37:3373\u20133380","journal-title":"Eur J Immunol"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-013-2705-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-013-2705-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-013-2705-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T15:45:37Z","timestamp":1688053537000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-013-2705-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,17]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["2705"],"URL":"https:\/\/doi.org\/10.1007\/s00296-013-2705-4","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,17]]}}}